Affymetrix Inc.

Affymetrix Inc. of Santa Clara, Calif., has granted Tessarae Inc. of McLean, Va., nonexclusive access to its microarray technology. The TessArray kits incorporate Affymetrix CustomSeq resequencing arrays and can detect and identify strains of viral and bacterial pathogens associated with upper respiratory diseases on the basis of target genome sequences. The epidemiological tests are intended primarily for public health and bioterrorism surveillance applications.





LATEST NEWS

• Functional Materials Developer Meta Materials to Lay off 80% of Workforce
  May 7, 2024
• Luminar Restructuring Includes 20% Workforce Cut
  May 7, 2024
• Danish Authorities Approve Sale of NKT Photonics to Hamamatsu
  May 6, 2024
• Photonic Processor Boosts Multifunctionality for Next-Gen Networks and AI
  May 6, 2024
• Imec Venture Fund Launches with $323M
  May 6, 2024
• The Winds of Change Are Blowing Through the Photonics Industry
  May 3, 2024
• PsiQuantum to Build Utility-Scale Quantum Computer in Australia
  May 3, 2024
• Tyndall, MIT Partner on Sustainable Chip Production Processes: Week in Brief: 5/3/24
  May 3, 2024